GAM Holding’s TherapeuticsMD TXMD Stock Holding History

GAM Holding’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,357	Closed	-$6.53M	–	972
2016 Q2	$6.53M	Sell	15,357 -8,698	-36%	-$3.58M	0.1%	251
2016 Q1	$7.7M	Sell	24,055 -4,100	-15%	-$1.4M	0.13%	188
2015 Q4	$14.6M	Hold	28,155	–	–	0.23%	117
2015 Q3	$8.25M	Buy	28,155 +2,636	+10%	+$937K	0.14%	176
2015 Q2	$10M	Hold	25,519	–	–	0.15%	169
2015 Q1	$7.72M	Hold	25,519	–	–	0.12%	202
2014 Q4	$5.67M	Buy	25,519 +3,539	+16%	+$730K	0.08%	264
2014 Q3	$5.09M	Buy	21,980 +6,571	+43%	+$1.66M	0.07%	292
2014 Q2	$3.4M	Buy	15,409 +1,680	+12%	+$374K	0.05%	373
2014 Q1	$4.33M	Buy	13,729 +5,180	+61%	+$1.65M	0.07%	308
2013 Q4	$2.23M	Hold	8,549	–	–	0.04%	426
2013 Q3	$1.25M	Buy	8,549 +2,694	+46%	+$326K	0.02%	606
2013 Q2	$890K	Buy	+5,855	New	+$802K	0.02%	547

Other funds holding TXMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

GAM Holding's TXMD Position: Q3 2016 in Review

GAM Holding sold out of TherapeuticsMD (TXMD) in Q3 2016, closing a stake of 15,357 shares — an estimated $6.53M sold.

GAM Holding first reported a position in TXMD in Q2 2013 and held it in 13 quarters. The position peaked at $14.6M in Q4 2015. 137 funds tracked by Wall St. Rank hold TXMD as of Q3 2016.

GAM Holding reported no remaining TherapeuticsMD position as of Q3 2016 after selling out during the quarter.
GAM Holding sold 15,357 TherapeuticsMD shares in Q3 2016, an estimated $6.53M.
GAM Holding first reported a position in TherapeuticsMD in Q2 2013 and held it in 13 quarters.
GAM Holding's TherapeuticsMD position peaked at $14.6M in Q4 2015.
137 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2016.

Based on GAM Holding's 13F filing for Q3 2016, filed 7 Nov 2016.